T-3262、NY-198、氟罗沙星（AM-833；RO 23-6240）及其他新型喹诺酮类药物对临床分离沙眼衣原体菌株的体外活性。
In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.
作者信息
Maeda H, Fujii A, Nakata K, Arakawa S, Kamidono S
机构信息
Department of Urology, School of Medicine, Kobe University, Japan.
出版信息
Antimicrob Agents Chemother. 1988 Jul;32(7):1080-1. doi: 10.1128/AAC.32.7.1080.
Abstract
The in vitro activities of three newly developed quinolone drugs (T-3262, NY-198, and fleroxacin [AM-833; RO 23-6240]) against 10 strains of clinically isolated Chlamydia trachomatis were assessed and compared with those of other quinolones and minocycline. T-3262 (MIC for 90% of isolates tested, 0.1 microgram/ml) was the most active of the quinolones. The NY-198 and fleroxacin MICs for 90% of isolates were 3.13 and 62.5 micrograms/ml, respectively.
摘要
评估了三种新开发的喹诺酮类药物（T-3262、NY-198和氟罗沙星[AM-833；RO 23-6240]）对10株临床分离沙眼衣原体的体外活性，并与其他喹诺酮类药物和米诺环素进行了比较。T-3262（90%受试分离株的MIC为0.1微克/毫升）是喹诺酮类药物中活性最强的。NY-198和氟罗沙星对90%分离株的MIC分别为3.13和62.5微克/毫升。
相似文献
1
In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.T-3262、NY-198、氟罗沙星（AM-833；RO 23-6240）及其他新型喹诺酮类药物对临床分离沙眼衣原体菌株的体外活性。
Antimicrob Agents Chemother. 1988 Jul;32(7):1080-1. doi: 10.1128/AAC.32.7.1080.
2
Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.AM-1155与妥舒沙星和氟罗沙星对携带GyrA和ParC喹诺酮耐药性改变的淋病奈瑟菌临床分离株的体外抗菌活性比较。
Chemotherapy. 1997 Jul-Aug;43(4):239-44. doi: 10.1159/000239573.
3
In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.氧氟沙星及其他四种新型喹啉羧酸对沙眼衣原体的体外活性
Antimicrob Agents Chemother. 1988 Nov;32(11):1735-7. doi: 10.1128/AAC.32.11.1735.
4
In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.司帕沙星、妥舒沙星、环丙沙星和氟罗沙星的体外活性。
Antimicrob Agents Chemother. 1991 May;35(5):955-60. doi: 10.1128/AAC.35.5.955.
5
Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates.在使用一组耐环丙沙星临床分离株进行挑战研究后，对克林沙星（CI-960、AM-1091、PD127371）和氟罗沙星（Ro 23-6240、AM-833）的纸片扩散药敏试验标准的修改。
Diagn Microbiol Infect Dis. 1995 Apr;21(4):209-13. doi: 10.1016/0732-8893(94)00061-z.
6
In vitro activities of five quinolones against Chlamydia pneumoniae.五种喹诺酮类药物对肺炎衣原体的体外活性
Antimicrob Agents Chemother. 1992 Mar;36(3):682-3. doi: 10.1128/AAC.36.3.682.
7
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
J Antimicrob Chemother. 1987 Sep;20(3):363-72. doi: 10.1093/jac/20.3.363.
8
In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.新型三氟喹诺酮衍生物氟罗沙星（Ro 23 - 6240）的体外研究
Chemotherapy. 1988;34(5):401-10. doi: 10.1159/000238599.
9
In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.新型氟喹诺酮类药物AM - 1155对衣原体属的体外和体内活性
Antimicrob Agents Chemother. 1997 Jun;41(6):1331-4. doi: 10.1128/AAC.41.6.1331.
10
In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains.洛美沙星（SC 47111或NY - 198）对沙眼衣原体菌株的体外活性。
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):87S-88S. doi: 10.1016/0732-8893(89)90072-2.
引用本文的文献
1
Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.氟罗沙星。对其在各种感染中的药理学及治疗效果的综述。
Drugs. 1995 May;49(5):794-850. doi: 10.2165/00003495-199549050-00010.
2
In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis.替马沙星（A - 62254）及其他四种抗生素对沙眼衣原体的体外活性
Antimicrob Agents Chemother. 1989 Jan;33(1):118-9. doi: 10.1128/AAC.33.1.118.
3
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
4
Quinolones in urology.喹诺酮类药物在泌尿外科中的应用
Urol Res. 1989;17(2):117-24. doi: 10.1007/BF00262033.
5
Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.氟罗沙星治疗单纯性沙眼衣原体生殖器感染的剂量范围研究。
Antimicrob Agents Chemother. 1989 Oct;33(10):1774-7. doi: 10.1128/AAC.33.10.1774.
6
In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.妥舒沙星（A-61827；T-3262）对特定生殖道病原体的体外活性。
Antimicrob Agents Chemother. 1990 Jun;34(6):971-3. doi: 10.1128/AAC.34.6.971.
7
Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.洛美沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1991 Dec;42(6):1018-60. doi: 10.2165/00003495-199142060-00009.
8
Fleroxacin clinical pharmacokinetics.氟罗沙星的临床药代动力学。
Clin Pharmacokinet. 1992 Feb;22(2):116-31. doi: 10.2165/00003088-199222020-00003.
9
In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.司帕沙星、其他喹诺酮类药物及四环素类药物对沙眼衣原体的体外和体内活性
Antimicrob Agents Chemother. 1992 Jan;36(1):188-90. doi: 10.1128/AAC.36.1.188.
本文引用的文献
1
Epidemiology of chlamydial infection of the human genital tract: evidence for the existence of latent infections.人类生殖道衣原体感染的流行病学：潜伏感染存在的证据。
Eur J Clin Microbiol. 1982 Apr;1(2):69-75. doi: 10.1007/BF02014194.
2
Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.通过间接免疫荧光法评估氧氟沙星和四环素对沙眼衣原体的体外活性比较。
Antimicrob Agents Chemother. 1984 Jul;26(1):13-6. doi: 10.1128/AAC.26.1.13.
3
Sexually transmitted organisms and infertility: the proof of the pudding.性传播病原体与不孕症：实践检验真理。
Sex Transm Dis. 1984 Apr-Jun;11(2):113-6.
4
Genital infection in men.男性生殖器感染
Br Med Bull. 1983 Apr;39(2):133-7. doi: 10.1093/oxfordjournals.bmb.a071804.
5
In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.环丙沙星、诺氟沙星、吡哌酸、西诺沙星和萘啶酸对沙眼衣原体的体外活性
Antimicrob Agents Chemother. 1984 Jan;25(1):123-4. doi: 10.1128/AAC.25.1.123.
6
Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis.
J Urol. 1985 Oct;134(4):691-3. doi: 10.1016/s0022-5347(17)47387-3.
7
Activities of new quinoline derivatives against genital pathogens.新型喹啉衍生物对生殖系统病原体的活性。
Antimicrob Agents Chemother. 1985 Jan;27(1):76-8. doi: 10.1128/AAC.27.1.76.
8
Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis.诺氟沙星未能根除非淋菌性尿道炎中的沙眼衣原体。
Antimicrob Agents Chemother. 1986 Oct;30(4):594-7. doi: 10.1128/AAC.30.4.594.
9
Treatment of nongonococcal urethritis with ciprofloxacin.环丙沙星治疗非淋菌性尿道炎
Am J Med. 1987 Apr 27;82(4A):311-6.
10
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
Infection. 1986;14 Suppl 4:S316-7. doi: 10.1007/BF01661306.
Zotero 插件